Catechol-Bearing Hyaluronic Acid Coated Polyvinyl Pyrrolidone/Hydroxyl Propyl-β-Cyclodextrin/Clotrimazole Nanofibers for Oral Candidiasis Treatment

Article Preview

Abstract:

This research aimed to develop clotrimazole (CT)-loaded mucoadhesive nanofiber patches for oral candidiasis. The three-layered sandwich-like nanofiber patches were prepared by electrospinning technique. The spinning solution for the middle layer composed of 8 %wt polyvinylpyrrolidone (PVP), 90 mM hydroxy propyl-β-cyclodextrin (HPβCD) and 10 % (wt to polymer) of CT in a solvent mixture of ethanol:water:benzyl alcohol. The outer layers were fabricated from a mixture of 1 %wt hyaluronic acid (HA) or catechol bearing hyaluronic acid (HA-cat) and 10 %wt polyvinyl alcohol (PVA) at varied weight ratios. The thickness of the outer layers was varied by adjusting the volume of coating polymer solution ranging from 1 to 3 mL. Desirable smooth nanosized fibers were obtained from the electrospinning process. Increasing the thickness of the outer layer brought about a significant increase in the fiber strength and flexibility. The viscosity of HA-cat/mucin mixture showed good polymer-mucin interaction indicating higher mucoadhesive property of the nanofibers. The drug loading capacity (LC) displayed the potential of the nanofibers for drug encapsulation. The highest LC value of 123.80 ± 5.61 μg/mg was obtained from the nanofibers coated with 1 mL of the coating solution. CT was rapidly released from the nanofiber in the first hour followed by a steady release. The released amount reach above 80% in 2 h. The nanofibers provided superior antifungal activity against Candida albicans compared to CT powder. Moreover, they were found to be nontoxic to the human gingival fibroblast cells. Thus, the sandwich nanofibers may be further developed to be a potential candidate for oral candidiasis treatment in the near future.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

163-168

Citation:

Online since:

August 2019

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2019 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] P. D. Crowley, H. C. Gallagher, Clotrimazole as a pharmaceutical: past, present and future, J Appl Microbiol. 117 (2014) 611-617.

DOI: 10.1111/jam.12554

Google Scholar

[2] J. L. Soriano-Ruiz, J. Suñer-Carbó, A. C. Calpena-Campmany, N. Bozal-de Febrer, L. Halbaut-Bellowa, A. Boix-Montañés, et al., Clotrimazole multiple W/O/W emulsion as anticandidal agent: Characterization and evaluation on skin and mucosae, Colloids and Surfaces B: Biointerfaces. 175 (2019) 166-174.

DOI: 10.1016/j.colsurfb.2018.11.070

Google Scholar

[3] P. Tonglairoum, T. Ngawhirunpat, T. Rojanarata, S. Panomsuk, R. Kaomongkolgit, P. Opanasopit, Fabrication of mucoadhesive chitosan coated polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for oral candidiasis, Carbohydrate Polymers. 132 (2015) 173-179.

DOI: 10.1016/j.carbpol.2015.06.032

Google Scholar

[4] J. Li, A. He, C. C. Han, D. Fang, B. S. Hsiao, B. Chu, Electrospinning of hyaluronic acid (HA) and HA/gelatin blends, Macromolecular Rapid Communications. 27 (2006) 114-120.

DOI: 10.1002/marc.200500726

Google Scholar

[5] E. Entekhabi, M. Haghbin Nazarpak, F. Moztarzadeh, A. Sadeghi, Design and manufacture of neural tissue engineering scaffolds using hyaluronic acid and polycaprolactone nanofibers with controlled porosity, Mater Sci Eng C Mater Biol Appl. 69 (2016) 380-387.

DOI: 10.1016/j.msec.2016.06.078

Google Scholar

[6] D. G. Yu, J. J. Li, G. R. Williams, M. Zhao, Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review, J Control Release. 292 (2018) 91-110.

DOI: 10.1016/j.jconrel.2018.08.016

Google Scholar

[7] K. Kim, K. Kim, J. H. Ryu, H. Lee, Chitosan-catechol: A polymer with long-lasting mucoadhesive properties, Biomaterials. 52 (2015) 161-170.

DOI: 10.1016/j.biomaterials.2015.02.010

Google Scholar